Laxavit 12 ml rect. sol. applic.

Country: Belġju

Lingwa: Ingliż

Sors: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingredjent attiv:

Docusate Sodium 249,96 mg/12 ml; Glycerol 14,85 g/12 ml

Disponibbli minn:

Kela Pharma SA-NV

Kodiċi ATC:

A06AG10

INN (Isem Internazzjonali):

Docusate Sodium; Glycerol

Dożaġġ:

12 ml

Għamla farmaċewtika:

Rectal solution

Kompożizzjoni:

Docusate Sodium 20.83 mg/ml; Glycerol 1237.17 mg/ml

Rotta amministrattiva:

Rectal use

Żona terapewtika:

Docusate Sodium, Incl. Combinations

Sommarju tal-prodott:

CTI code: 114922-03 - Pack size: 10 x 12 ml - Commercialisation status: NO - Delivery mode: Free delivery; CTI code: 114922-02 - Pack size: 3 x 12 ml - Commercialisation status: YES - CNK code: 0057448 - Delivery mode: Free delivery; CTI code: 114922-01 - Pack size: 12 ml - Commercialisation status: NO - CNK code: 0861674 - Delivery mode: Free delivery; CTI code: 114922-04 - Pack size: 50 x 12 ml - Commercialisation status: YES - CNK code: 1097906 - Delivery mode: Free delivery

L-istatus ta 'awtorizzazzjoni:

Commercialised: Yes

Data ta 'l-awtorizzazzjoni:

1980-04-01